Pediatricians' Group Recommends COVID-19 Vaccines for Young Children, Diverging from CDC Guidelines

The American Academy of Pediatrics has issued new COVID-19 vaccine recommendations for children, diverging from CDC guidance. The new guidelines advocate for broader vaccination coverage, especially for high-risk kids, amid rising cases and policy shifts, emphasizing individual choice and updated safety data.
In a significant shift, the American Academy of Pediatrics (AAP) has issued new recommendations for COVID-19 vaccination in children, which differ from those provided by the Centers for Disease Control and Prevention (CDC). Historically, vaccine advice from these organizations has been closely aligned for over three decades. However, as of August 19, 2025, the AAP has published guidelines advocating for broader access to COVID-19 vaccines for children,
particularly emphasizing vaccination for those aged 6 months to 23 months and offering vaccination options for children and teens aged 2 to 18, especially those at higher risk due to underlying health conditions or living in group settings.
This new guidance suggests that all children in the 6 to 23-month age group should receive a complete vaccine series, following previous recommendations. For older children and adolescents, the AAP recommends a single dose for those deemed at higher risk, unlike the CDC's approach, which emphasizes shared clinical decision-making for children aged 6 months to 17 years. This difference stems from the recent political and institutional shifts affecting vaccine policy, including the dismissal of the CDC’s Advisory Committee on Immunization Practices, which historically provided independent guidance.
The divergence is partly driven by concerns over the credibility and transparency of CDC recommendations in the current political climate, with the AAP citing independent evidence that Young children and those with certain health issues remain especially vulnerable to COVID-19, despite a decline in risk for healthier older children. The latest reviews show vaccines continue to be safe and effective, with no new safety concerns.
Implementation of these guidelines faces challenges, including potential insurance coverage issues, supply constraints, and policy differences among providers. While the AAP advocates for expanded vaccination, federal agencies and policymakers will need to decide whether to integrate these recommendations fully.
Parents and caregivers are encouraged to consult their pediatricians to determine the best vaccination strategies amid ongoing changes and rising COVID-19 cases. The upcoming CDC meetings may influence future policy, but for now, the AAP's recommendations highlight a more inclusive approach to childhood COVID-19 prevention, emphasizing availability and individual choice.
Source: https://medicalxpress.com/news/2025-08-pediatricians-association-covid-vaccines-toddlers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Phase I Study Shows Topical PXS-6302 Is Safe and Tolerable for Skin Scar Treatment
A Phase I trial shows that topical PXS-6302 is safe and well tolerated for treating established skin scars, with promising biochemical effects indicating potential for scar remodeling.
Vaginal Estrogen Tablets Found Safe for Postmenopausal Women After Stroke
New research suggests that vaginal estrogen tablets are safe for postmenopausal women with a history of stroke, showing no increased risk of recurrent ischemic strokes. This offers a promising option for managing menopausal symptoms without elevating stroke risk.
Advanced AI Identifies Five Unique Cancer Cell Groups Within Tumors
A pioneering AI tool developed by researchers has uncovered five distinct cancer cell groups within individual tumors, paving the way for more personalized and effective cancer therapies.
U.S. Government Considers Linking Tylenol to Autism Risks
The Trump administration is considering linking acetaminophen, the active ingredient in Tylenol, to autism risk and advising pregnant women to avoid its use unless necessary. This move reflects ongoing debates about medication safety during pregnancy.



